BCRX
NASDAQ
$9.11
Biocryst Pharmaceuticals Inc (BCRX)
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
Sector:
Healthcare
Strong Buy
Target: $21 (+130.52%)
Market Cap
$2.39B
Revenue 5Y CAGR
+94.22%
Free Cash Flow Yield
13.10%
Beta (5Y)
0.77
Price Chart
Valuation
Market Cap$2.39B
Forward P/E86.96
P/S2.79
P/B56.59
Profitability
Total Revenue (TTM)$886M
Gross Profit (TTM)$679M
EBITDA-$380M
Profit Margin-51.7%
Operating Margin-2.4%
EPS-$1.60
Financial Health
Debt-to-Equity-71.4%
Free Cash Flow Yield13.10%
Growth & Risk
EPS 5Y CAGR+6.24%
Revenue 5Y CAGR+94.22%
Beta (5Y)0.77
Sharpe Ratio0.25